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Abstract Objectives: To validate
the SAPS 3 admission score in an
independent general intensive care
case mix and to compare its perfor-
mances with the APACHE II and the
SAPS II scores. Design: Cohort
observational study. Setting: A 26-
bed general ICU from a Tertiary
University Hospital. Patients and
participants: Eight hundred and
fifty-one consecutive patients admit-
ted to the ICU over an 8-month
period. Of these patients, 49 were
readmissions, leaving 802 patients for
further analysis. Interven-
tion: None. Measurements and
results: APACHE II, SAPS II and
SAPS 3 variables were prospectively
collected; scores and their derived
probability of death were calculated
according to their original manuscript
description. The discriminative power
was assessed using the area under the
ROC curve (AUROC) and calibration
was verified with the Hosmer–Leme-
show goodness-of-fit test. The
AUROC of the APACHE II model
(AUROC = 0.823) was significantly
lower than those of the SAPS II
(AUROC = 0.850) and SAPS 3
models (AUROC = 0.854)
(P = 0.038). The calibration of the
APACHE II model (P = 0.037) and
of the SAPS 3 global model
(P = 0.035) appeared unsatisfactory.
On the contrary, both SAPS II model
and SAPS 3 model customised for
Central and Western Europe had a
good calibration. However, in our
study case mix, SAPS II model ten-
ded to overestimate the probability of
death. Conclusion: In this study, the
SAPS 3 admission score and its pre-
diction model customised for Central
and Western Europe was more dis-
criminative and better calibrated than
APACHE II, but it was not signifi-
cantly better than the SAPS II.
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Introduction
The first scoring systems dedicated to the assessment of
severity of illness of ICU patients were launched more
than 25 years ago. Among these severity of illness scoring
systems, the second version of the Acute Physiology and
Chronic Health Evaluation score (APACHE II) [1]
became used worldwide. Although more recent severity
scores versions were developed in the nineties [2–4], the
APACHE II remains, to date, the most widely used
scoring system for ICUs assessment and for clinical trials
conducted in the field of critical care medicine. Never-
theless, several studies showed a deterioration of both
APACHE II and SAPS II scores performances [5–8]. The
recently published SAPS 3 admission score [9] is a model
built to predict hospital mortality from admission data
(recorded within ±1 h). This model is based on a large
cohort of patients (16,784 patients) consecutively
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admitted to 303 intensive care units from 35 countries
around the world [10]. From this admission score are
derived not only a global equation for hospital mortality
prediction based on the whole case mix, but also equa-
tions customised for different geographic regions.
Although the SAPS 3 admission model is a promising and
elegant tool, there is a need for its external validation to
verify its performances on an independent population
sample.
The first aim of the present study was to assess SAPS 3
admission score in a patients’ cohort from a mixed
medico-surgical ICU located in a Western Europe coun-
try. A secondary end point of the study was to compare
the SAPS 3 score performances with those of the older
APACHE II and SAPS II scores.
Material and methods
The study was conducted in a 26-bed general intensive
care unit at the Liege University Hospital, Belgium. Data
were analysed on all consecutive admissions over an
8-month period. For patients admitted more than once to
the ICU during their hospital stay, only data recorded
during the first ICU admission were analysed. As for the
APACHE II and SAPS 3 scores [10, 11], patients under
16 years of age were excluded from the analysis. Burns
were also excluded from the study, since in our institution,
these patients are treated in a specific burns unit. Finally,
we decided to include patients admitted after heart surgery
in the case mix, since those patients are taken into account
in the SAPS 3 admission score. In addition, previous
studies showed that performance of the APACHE II and
SAPS II is adequate in case mix of patients admitted to the
ICU after heart surgery [12]. Additional information on
exclusion criteria may be found in the electronic supple-
mentary material (ESM). The institutional human research
ethics committee waived the need for informed consent,
since no patient intervention was required and patient
anonymity was preserved.
Data collection, computer entry and processing
Data were collected prospectively by a research nurse
with a previous experience in data collection for the
APACHE II and SAPS II scores. That nurse was trained
for SAPS 3 variables collection and she had access to the
variables definitions published in the ESM from the ori-
ginal SAPS 3 paper [10]. Data were collected on paper
form complying with the original publications method-
ology [1, 3, 9] and then encoded on the ICU database.
Data were imported into a spreadsheet (Microsoft Excel
2003, Microsoft Corporation) for the calculation of the
scores and their derived probabilities of death using the
published equations and coefficients.
Statistical analysis
The study was powered to assess a difference between
areas under the ROC curves (AUROC) of the APACHE II
model and SAPS 3 model customized for Central and
Western Europe [13, 14]. The AUROC used for power
calculation were obtained from historical observations
made in our ICU for APACHE II model (AUROC =
0.816 on a cohort of 1,221 consecutive patients admitted
to the ICU during the year 2004) and from the AUROC
published in the original SAPS 3 paper (AUROC = 0.861
for Central and Western Europe) [9]. The decision to use
APACHE II AUROC rather than SAPS II AUROC to
define sample size was based on two considerations: first,
we wanted to challenge the APACHE II; second, although
this was not statistically significant, in our historical case
mix, APACHE II AUROC (0.816, 95% CI 0.787–0.846)
was higher than SAPS II AUROC (0.803, 95% CI 0.768–
0.839); sample size calculation was therefore also ade-
quate to assess SAPS II. A sample of 780 patients was
required in the study to reach an 80% power. Continuous
variables are reported as the median and interquartile
range (IQR) or as mean ± standard deviation. Categorical
variables are reported as the count and percentage. For
each score, the discriminative power was assessed using
the AUROC. The calibration was evaluated with the
Hosmer–Lemeshow goodness-of-fit Cˆ test. A P value
above 0.05 at the Hosmer–Lemeshow goodness-of-fit test
indicated a good calibration. The areas under the ROC
curves were compared using the method described by
DeLong et al. [15]. The standard mortality ratios (SMRs)
were calculated as the ratio between observed mortality
and expected mortality based on the severity score mod-
els. The 95% confidence interval of the SMRs were
computed using the method described by Rapoport et al.
[16]. Statistical analyses were performed using SAS
(version 9.1.3 Service Pack 4, SAS Institute Inc., Cary,
NC, USA) and STATA software (version 8.0, Stata
Corporation, Texas, USA). A two-tailed P value below
0.05 was considered statistically significant.
Results
Patients’ case mix
Over the 8-month period, from December 2005 to July
2006, 865 patients were admitted to the ICU. Forty-nine
of these patients (5.7%) were readmitted during the same
hospital stay and 14 patients (1.6%) were younger than
16 years of age. Those patients were not included in the
study, leaving 802 (92.3%) patients for analysis. The data
used to derive APACHE II, SAPS2 and SAPS 3 scores
and probabilities of death were collected in all these
patients. Patient’s characteristics are presented in Table 1.
Apart from basic and observational admission (n = 105/
802, 13%), the main reasons for ICU admission were as
follows: cardiovascular, respiratory and neurological.
These reasons encountered for 70% of the ICU admis-
sions. Additional details on patients’ characteristics may
be found in the ESM (Tables E2 and E3, ESM). During
the study period, the overall hospital mortality was 140
(17.5%) patients.
Performance of the scoring systems
Performances of the three models are summarized in
Table 2. The discriminative power, assessed using the
AUROC, was significantly lower for the APACHE II
model (AUROC 0.823 ± 0.020) as compared with SAPS
II (AUROC 0.850 ± 0.019) and SAPS 3 (AUROC
0.854 ± 0.019) model (P = 0.037) (Fig. E1, ESM). The
Hosmer–Lemeshow goodness-of-fit test (Cˆ) revealed a
poor calibration for the APACHE II models (Cˆ = 16.38,
P = 0.037) and for the SAPS 3 global model (Cˆ = 16.59,
P = 0.035). On the contrary, the calibration of SAPS II
model (Cˆ = 5.78, P = 0.671) and SAPS 3 customized for
Central and Western Europe (Cˆ = 8.30, P = 0.405) was
appropriate (Fig. 1). The analysis of the standardised
mortality ratios revealed that the best predictive results
were achieved with the SAPS 3 model customized for
Central and Western Europe. The global SAPS 3 model
significantly overestimated hospital mortality; the 95%
confidence interval did not indeed contain 1 (SMR =
0.82; 95% CI 0.70–0.93). While APACHE II tended to
underestimate mortality, the SAPS II model, on the con-
trary, tended to overestimate mortality (Fig. 2E, ESM).
Discussion
Both the global model and the model customised for
Central and Western Europe of the SAPS 3 admission
score had a very good discriminative power as shown by
an AUROC very close to the one published in the ori-
ginal SAPS 3 paper [9]. However, the fit of the global
SAPS 3 mortality prediction model was inadequate in
our patients’ sample from a Western Europe ICU. The
global SAPS 3 model significantly overestimated hos-
pital mortality in our studied patients’ cohort. These
findings are not surprising, since, in the original SAPS 3
hospital outcome cohort, Moreno et al. already reported
that the SAPS 3 global mortality prediction model fit
was poor for Central and Western Europe ICUs [9]. On
the contrary, the SAPS 3 model customized for Central
and Western Europe region was adequate. The discrim-
inative power was very good, close to the one published
in the original publication, and the calibration was
appropriate. Moreover, this model produced the best
predictive results as shown by a standardised mortality
ratio close to one.
The present study shows that older severity of illness
scoring systems performances may not be satisfactory
anymore. In our patients’ case mix, the APACHE II score
suffered from both a lower discriminative power, as
compared with the other assessed severity scores, and
from a significant lack of calibration. These findings were
previously described by several authors [5, 17]. Never-
theless, other authors found acceptable calibration of the
APACHE II score even in recent case mix population
sample [18, 19]. It appears however that the APACHE II
score is nowadays outdated. Interestingly, Knaus, the
APACHE II original developer, advised that researchers
should discontinue the use of the APACHE II for outcome
assessment [20].
In our patients’ sample, the SAPS II score performed
well, its discriminative power was very good and its
Table 1 Patients’ demographic characteristics
Patients’ characteristics
Age (years), median (IQR) 66 (53–75)
Male, n (%) 486 (60.6)
No surgery, n (%) 232 (28.9)
Scheduled surgery, n (%) 397 (49.5)
Unscheduled surgery, n (%) 173 (21.6)
Origin
Home 109 (13.6)
Same hospital 551 (68.7)
Chronic care facility 1 (0.1)
Public place 11 (1.4)
Other hospital 130 (16.2)
Co-morbidities
Alcoholism 69 (8.6)
Arterial hypertension 444 (55.6)
Chemotherapy 10 (1.3)
Chronic heart failure 355 (44.4)
Chronic pulmonary failure 18 (2.3)
COPD 127 (15.9)
Chronic renal failure 39 (4.9)
Cirrhosis 25 (3.1)
EV drug addict 6 (0.8)
Haematological cancer 17 (2.1)
HIV positive 3 (0.4)




Steroid treatment 13 (1.6)
Ventilated on admission, n (%) 594 (74.1)
Length of stay in ICU (days), median (IQR) 3 (2–7)
Length of stay in hospital (days), median (IQR) 14 (10–26)
ICU mortality, n (%) 106 (13.2)
Hospital mortality, n (%) 140 (17.5)
Definition for co-morbidities can be found in the electronic sup-
plementary material of the original SAPS 3 paper
calibration was appropriate. These results are divergent
from most published results. Several authors indeed
showed that if the SAPS II model has a good discrimi-
native power, its calibration is poor when applied to an
independent case mix [8, 17]. However, although it
seemed to perform adequately in our patients’ sample, we
found, like other authors, that the SAPS II predictive
model tended to overestimate the hospital mortality
[8, 17, 18].
The present study has potential limitations. One could
criticize the relatively small sample size of the study;
however, it was designed to be adequately powered to
detect differences between APACHE II or SAPS II and
SAPS 3 AUROC. Another potential limitation is related
to the fact that the present work is a single-centre study
with a different patients’ case mix as compared to the
original SAPS 3 hospital outcome cohort, and these
results may not be generalisable to other ICUs. Finally,
one could criticize the fact that in the present study there
was no assessment of data collector reliability. Although
this is an important issue, we are quite confident that, in
this work, bias related to inadequate data collection was
limited, since collection was done by one trained research
nurse. Previous studies showed indeed that, in such con-
dition, interobserver variability was reduced [21].
In conclusion, in the present study, we found that the
SAPS 3 admission score was superior to the APACHE II
model. However, in our case mix, it was not significantly
better than the SAPS II score, both having a good dis-
criminative power and calibration.
Table 2 Area under the receiver-operating characteristic curve, Hosmer–Lemeshow goodness-of-fit test and standardised mortality ratios





Area under ROC curve Goodness-of-fit
Cˆ test
SMR
AUC (95% CI)) P value* Cˆ P value (95% CI)
APACHE II equation 13.3 ± 6.5 15.9 ± 19.1 0.82 (0.78–0.86) 0.037 16.38 0.037 1.10 (0.97–1.24)
SAPS II equation 33.1 ± 14.5 19.7 ± 22.0 0.85 (0.81–0.89) 5.78 0.671 0.89 (0.77–1.01)
SAPS 3 global equation 48.9 ± 15.2 21.4 ± 21.9 0.85 (0.82–0.89) 16.59 0.035 0.82 (0.70–0.93)
SAPS 3 Central, Western
Europe equation
18.1 ± 21.0 0.85 (0.82–0.89) 8.30 0.405 0.96 (0.84–1.08)
ROC curve receiver-operating characteristic curve, AUC area under
the curve, SD standard deviation, 95% CI 95% confidence interval,
SMR standardised mortality ratio, APACHE acute physiology and
chronic health evaluation, SAPS simplified acute physiology score
*Comparison of APACHE II, SAPS II, SAPS 3 and customized
SAPS 3 using DeLong methods
Fig. 1 Hosmer–Lemeshow Cˆ
goodness-of-fit test; calibration
curves for the APACHE II,
SAPS II, global SAPS 3 (SAPS
3) and SAPS 3 customised for
Central and Western Europe
(SAPS 3w) models
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